
Hemlibra 105mg Injection
Marketer
Roche Products India Pvt Ltd
Salt Composition
Emicizumab (105mg)
Overview Hemlibra 105mg Injection
Emicizumab 105mg injection is a prophylactic treatment for hemophilia A patients of all ages, minimizing bleeding episodes. It facilitates normal blood clotting, thereby preventing bleeds associated with hemophilia A. Administration is exclusively by a healthcare professional; self-injection is strictly prohibited. Injection sites include the thighs, upper arms, and abdomen. Dosage and treatment length are individualized based on patient response and medical history. Consistent adherence to the prescribed regimen is crucial. Commonly reported adverse effects include injection site reactions (pain, redness, swelling), headache, and arthralgia. Report any adverse reactions, including those not listed, to your physician, who can offer management strategies. Prior to commencing treatment, disclose any allergies to the medication's components and provide a complete medical history, including all current medications. Women of childbearing age should utilize contraception during treatment and for six months post-treatment. Consult your physician regarding Hemlibra use during pregnancy or breastfeeding.
Primary Ingredients of Hemlibra 105mg Injection
There is no text provided to rephrase. Please provide the text you wish to be rewritten.
Uses of Hemlibra 105mg Injection
Managing Hemophilia A
Major Benefits of Hemlibra 105mg Injection:
Administering this medication will be done by your physician or their qualified associate; self-medication is strongly discouraged.
Common Side effects of Hemlibra 105mg Injection:
- Injection site reactions (pain, swelling, redness)
- Joint pain
- Headache
How to use Hemlibra 105mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Hemlibra 105mg Injection works:
Hemophilia A patients deficient in or lacking factor VIII experience impaired blood clotting. Hemlibra 105mg Injection facilitates coagulation by linking factor IXa and factor X, thus bypassing the need for factor VIII replacement.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Hemlibra 105mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on Hemlibra 105mg Injection use in pregnancy are lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Hemlibra 105mg Injection use while breastfeeding is lacking. Seek your physician's advice.
DrivingSAFE
Driving ability is typically unaffected by Hemlibra 105mg Injection.
KidneySAFE IF PRESCRIBED
For individuals with kidney impairment, Hemlibra 105mg Injection is considered safe. No modification of the Hemlibra 105mg Injection dosage is necessary.
LiverSAFE IF PRESCRIBED
For patients with hepatic impairment, Hemlibra 105mg Injection is considered safe and requires no dosage modification.
What if you forget to take Hemlibra 105mg Injection :
For Hemlibra 105mg Injection, administer any missed dose immediately upon recall. If your next scheduled dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never inject a double dose.
Facts to Know About Hemlibra 105mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
